Sep 2017 $3 M No. 4 $2 to $10 million 3
Analyte Health, Inc.: Raise no. 4, Sep 2017 × Investors in this round 3 investors had bought by the notice of Sep 29, 2017: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $4 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Franklin Cockerill III · Executive Officer, Director Kevin Weinstein · Executive Officer, Director Adam Koopersmith · Director Lon Chow · Director Phyllis Whiteley · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Kevin Weinstein, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Sep 29, 2017. Read the notice at the SEC .
equity SEC Feb 2016 $7 M No. 3 $2 to $10 million 3
Analyte Health, Inc.: Raise no. 3, Feb 2016 × Investors in this round 3 investors had bought by the notice of Feb 12, 2016: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $7 M of $7 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Franklin Cockerill III · Executive Officer, Director Adam Koopersmith · Director Lon Chow · Director Phyllis Whiteley · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Franklin Cockerill III, Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 12, 2016. Read the notice at the SEC .
equity SEC Jun 2012 $8 M No. 2 $2 to $10 million 5
Analyte Health, Inc.: Raise no. 2, Jun 2012 × Investors in this round 5 investors had bought by the notice of Jul 11, 2012: 5 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $8 M of $8 M offered
Smallest investment taken no minimum stated
What was sold equity, other: Shares of Series C Preferred Stock and the common stock issuable upon conversion.
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Daniel Malven · Executive Officer, Director Sridhar Murthy · Executive Officer, Director Lon Chow · Director Matthew McCall · Director Vance Vanier · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Proceeds to be used as working capital, including payment of director, officer and employee salaries.”Signed by Sridhar Murthy, Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 11, 2012. Read the notice at the SEC .
equity SEC Jun 2010 $3 M No. 1 $2 to $10 million 12
Analyte Health, Inc.: Raise no. 1, Jun 2010 × Investors in this round 12 investors had bought by the notice of May 17, 2011: 12 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $3 M offered
Smallest investment taken no minimum stated
What was sold equity, debt, options or other rights to buy securities, other: Secured Convertible Notes
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Dan Malven · Executive Officer, Director Michelle Sobel · Executive Officer, Director Sridhar Murthy · Executive Officer, Director Daniel Derman · Director Lon Chow · Director Matthew McCall · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Proceeds to be used as working capital, including payment of director, officer and employee salaries.”Signed by Sridhar Murthy, C.e.o.. Source: SEC Form D, newest notice filed May 17, 2011. Read the notice at the SEC .
equity, debt, options SEC Nov 2008 $1 M Issued in a merger or acquisition Under $2 million 4
Analyte Health, Inc.: Private sale, Nov 2008 × Investors in this round 4 investors had bought by the notice of May 17, 2011: 2 accredited, 2 not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Dan Malven · Executive Officer, Director Michelle Sobel · Executive Officer, Director Sridhar Murthy · Executive Officer, Director Daniel Derman · Director Lon Chow · Director Matthew McCall · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Proceeds to be used as working capital, including payment of director, officer and employee salaries.”On a merger: “Offer was made in connection with acquisition of Ajuga Media LLC's assets.”Signed by Sridhar Murthy, C.e.o.. Source: SEC Form D, newest notice filed May 17, 2011. Read the notice at the SEC .
equity SEC